Hepatitis B core total antibodies
Description:
Qualitative chemiluminescent immunoassay (CLIA) for the detection of total antibodies to Hepatitis B core in serum. A positive core antibody indicates past or current infection with Hepatitis B. Positive samples will undergo further testing for other Hepatitis B markers to determine whether there is chronic ongoing infection. Patients with a positive core antibody in isolation are still at risk of re-activating hepatitis B if significantly immunosuppressed. May be temporarily positive in patients who have recently received blood products, "false positive". This assay is available as a screening or follow-up test Mon to Sun, with a turnaround time of 3 working days.
This test is not UKAS accredited
This test is not UKAS accredited
Clinical details:
Hepatitis B infection can lead to significant liver disease which can be prevented either by pre-exposure vaccination or with medical treatment in chronic infection.
Reference range:
Not Applicable
Synonyms or keywords:
HepB, HBV, Core total
Units:
Qualitative test - Detected/Not detected
Department:
Location:
Sample type and Volume required:
2.5 – 5ml Yellow Top Serum Separation Tube (SST) Clotted Blood (for serum).
Turnaround time:
3 working days
Storage and transport:
Place labelled sample in a sealed sample bag and send to Central Specimen Reception (CSR). To prevent sample haemolysis, please store samples in refrigerator if there is a delay in sending samples to CSR.
Contacts:
For clinical advice or interpretation of results, please contact the laboratory in the first instance.
Laboratory:
Last updated: 18/12/2024
